Recent performance snapshot for Cardinal Health stock

With no single event driving headlines, Cardinal Health (CAH) has still drawn attention after a recent 1 day return of about a 1% decline and a 7 day move near a 4% decline.

Over the past month the stock shows roughly a 7% decline, while the past 3 months are roughly flat, with a small positive return near 0%. Year to date, the share price reflects about a 1% gain.

That recent share price weakness comes after a very strong run, with the 1 year total shareholder return at about 58% and the 3 and 5 year total shareholder returns above 200%, suggesting momentum has cooled in the short term.

If you are comparing Cardinal Health with other healthcare names tied to technology, it can help to widen the lens and scan 36 healthcare AI stocks

With shares easing back after a strong multi year run, Cardinal Health now trades at about a 20% discount to analyst price targets and an implied 58% discount to intrinsic value. Is this a fresh buying opportunity, or is the market already pricing in future growth?

Most Popular Narrative: 16.6% Undervalued

The most widely followed narrative values Cardinal Health at about $249 per share, compared with the recent close around $208. This frames a clear discount that hinges on specific growth and margin assumptions.

The analysts have a consensus price target of $180.462 for Cardinal Health based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $203.0, and the most bearish reporting a price target of just $150.0.

Want to see what underpins a fair value well above the current price? The narrative leans on steady top line expansion, gradual margin uplift and a richer earnings multiple tied to those future profits. Curious how those moving parts combine to get to that number?

Result: Fair Value of $249.27 (UNDERVALUED)

However, this hinges on continued execution, and tighter regulation or the loss of major customer contracts could quickly challenge the assumptions behind that upside story.

Another View: Earnings Multiple Tells A Different Story

The SWS DCF model points to a fair value near $496 per share, which is a very large premium to the recent $207.83 price and labels Cardinal Health as undervalued. That is a much stronger signal than the 16.6% gap in the popular narrative. How comfortable are you with the assumptions built into each approach?

Next Steps

Mixed signals on value and sentiment so far, right? Take a closer look at both sides of the story and weigh the 4 key rewards and 2 important warning signs.

Looking for more investment ideas?

If Cardinal Health has sparked your interest, do not stop here, widen your search with focused stock ideas that match how you like to invest.

• Target strong value by scanning 54 high quality undervalued stocks that combine quality fundamentals with prices that may sit below their estimated worth.
• Prioritize resilience by reviewing 72 resilient stocks with low risk scores that score well on financial strength and volatility filters.
• Hunt for potential future standouts with a screener containing 26 high quality undiscovered gems before they appear on everyone else's radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.